Observational studyBMC pulmonary medicine2018

Clinical and economic impact of a one-year treatment with omalizumab in patients with severe allergic asthma within a drug programme in Poland.

Karina Jahnz-Różyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.